Loading...
Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement
Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium–glucose co-transporter 2 inhibitors (SGLT2i) with their novel insulin-inde...
Na minha lista:
| Udgivet i: | Indian J Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5240067/ https://ncbi.nlm.nih.gov/pubmed/28217523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.196029 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|